EXJADE Removes Excess Iron in Transfusion-dependent Aplastic and Other Anemias

Aplastic and Other Anemias

In addition to the more common anemias, rare forms of acquired or inherited anemias also require multiple blood transfusions, either to provide effective treatment or offer relief from painful symptoms. However, excess iron that accumulates from these transfusions may lead to iron toxicity.1,2,3

Learn more about how EXJADE reduces toxic iron in patients with:

Categorizing other anemias and identifying iron toxicity

Identify patient characteristics and standard iron toxicity tests to evaluate risk.

Learn more

EXJADE efficacy demonstrated across anemias

Clinical studies with EXJADE have demonstrated chelation benefits (serum ferritin levels and liver iron concentration) in patients with aplastic and other anemias.

Learn more

WHAT IS EXJADE?

EXJADE is a once-daily oral iron-chelator.

Learn more

HOW ARE DIFFERENT ORGANS AFFECTED BY IRON TOXICITY?

Excess iron from transfusions can cause serious consequences in vital organs.

Learn more

SAFETY PROFILE ACROSS ANEMIAS

Learn more